Keywords: decision, s-p, claritin, follow-up, schering-plough, received, approvability
No decision on S-P's Claritin follow-up
Article | 31 October 2000
Schering-Plough has not received a decision on approvability from theUS Food and Drug Administration regarding its single-isomer desloratadine, the follow-up ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
